These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36719467)

  • 61. T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research.
    Chen Z; Ruan P; Wang L; Nie X; Ma X; Tan Y
    J Cell Mol Med; 2021 Jan; 25(2):1274-1289. PubMed ID: 33325143
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Deciphering the immunogenic T-cell epitopes from spike protein of SARS-CoV-2 concerning the diverse population of India.
    Devi SS; Kardam V; Dubey KD; Dwivedi M
    J Biomol Struct Dyn; 2023 Apr; 41(7):2713-2732. PubMed ID: 35132938
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
    Weisblum Y; Schmidt F; Zhang F; DaSilva J; Poston D; Lorenzi JC; Muecksch F; Rutkowska M; Hoffmann HH; Michailidis E; Gaebler C; Agudelo M; Cho A; Wang Z; Gazumyan A; Cipolla M; Luchsinger L; Hillyer CD; Caskey M; Robbiani DF; Rice CM; Nussenzweig MC; Hatziioannou T; Bieniasz PD
    Elife; 2020 Oct; 9():. PubMed ID: 33112236
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants.
    Meyer S; Blaas I; Bollineni RC; Delic-Sarac M; Tran TT; Knetter C; Dai KZ; Madssen TS; Vaage JT; Gustavsen A; Yang W; Nissen-Meyer LSH; Douvlataniotis K; Laos M; Nielsen MM; Thiede B; Søraas A; Lund-Johansen F; Rustad EH; Olweus J
    Cell Rep; 2023 Jan; 42(1):111995. PubMed ID: 36656713
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern.
    Martín-Galiano AJ; Díez-Fuertes F; McConnell MJ; López D
    Front Immunol; 2021; 12():732693. PubMed ID: 34899692
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunoinformatics Identification of the Conserved and Cross-Reactive T-Cell Epitopes of SARS-CoV-2 with Human Common Cold Coronaviruses, SARS-CoV, MERS-CoV and Live Attenuated Vaccines Presented by HLA Alleles of Indonesian Population.
    Gustiananda M; Julietta V; Hermawan A; Febriana GG; Hermantara R; Kristiani L; Sidhartha E; Sutejo R; Agustriawan D; Andarini S; Parikesit AA
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366426
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Suboptimal SARS-CoV-2-specific CD8
    Habel JR; Nguyen THO; van de Sandt CE; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Jia X; Chua B; Zhang W; Tan HX; Flanagan KL; Doolan DL; Torresi J; Chen W; Wakim LM; Cheng AC; Doherty PC; Petersen J; Rossjohn J; Wheatley AK; Kent SJ; Rowntree LC; Kedzierska K
    Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24384-24391. PubMed ID: 32913053
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human CD4
    Verhagen J; van der Meijden ED; Lang V; Kremer AE; Völkl S; Mackensen A; Aigner M; Kremer AN
    Clin Exp Immunol; 2021 Sep; 205(3):363-378. PubMed ID: 34061349
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 Treatment.
    Kim N; Lee JM; Oh EJ; Jekarl DW; Lee DG; Im KI; Cho SG
    Front Immunol; 2021; 12():751869. PubMed ID: 35003063
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of SARS-CoV-2 Omicron BA.1 Spike Mutations on T-Cell Epitopes in Mice.
    Wang Y; Wang B; Zhao Z; Xu J; Zhang Z; Zhang J; Chen Y; Song X; Zheng W; Hou L; Wu S; Chen W
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992472
    [TBL] [Abstract][Full Text] [Related]  

  • 71. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
    Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
    Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose.
    Belik M; Liedes O; Vara S; Haveri A; Pöysti S; Kolehmainen P; Maljanen S; Huttunen M; Reinholm A; Lundberg R; Skön M; Österlund P; Melin M; Hänninen A; Hurme A; Ivaska L; Tähtinen PA; Lempainen J; Kakkola L; Jalkanen P; Julkunen I
    Front Immunol; 2023; 14():1099246. PubMed ID: 36756112
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination.
    Riise J; Meyer S; Blaas I; Chopra A; Tran TT; Delic-Sarac M; Hestdalen ML; Brodin E; Rustad EH; Dai KZ; Vaage JT; Nissen-Meyer LSH; Sund F; Wader KF; Bjornevik AT; Meyer PA; Nygaard GO; König M; Smeland S; Lund-Johansen F; Olweus J; Kolstad A
    Br J Haematol; 2022 Jun; 197(6):697-708. PubMed ID: 35254660
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country.
    Requena D; Médico A; Chacón RD; Ramírez M; Marín-Sánchez O
    Front Immunol; 2020; 11():2008. PubMed ID: 33013857
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.
    Nathan A; Rossin EJ; Kaseke C; Park RJ; Khatri A; Koundakjian D; Urbach JM; Singh NK; Bashirova A; Tano-Menka R; Senjobe F; Waring MT; Piechocka-Trocha A; Garcia-Beltran WF; Iafrate AJ; Naranbhai V; Carrington M; Walker BD; Gaiha GD
    Cell; 2021 Aug; 184(17):4401-4413.e10. PubMed ID: 34265281
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The T Cell Epitope Landscape of SARS-CoV-2 Variants of Concern.
    Tennøe S; Gheorghe M; Stratford R; Clancy T
    Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891287
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors.
    Wu D; Kolesnikov A; Yin R; Guest JD; Gowthaman R; Shmelev A; Serdyuk Y; Dianov DV; Efimov GA; Pierce BG; Mariuzza RA
    Nat Commun; 2022 Jan; 13(1):19. PubMed ID: 35013235
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characterization of Magnitude and Antigen Specificity of HLA-DP, DQ, and DRB3/4/5 Restricted DENV-Specific CD4+ T Cell Responses.
    Grifoni A; Moore E; Voic H; Sidney J; Phillips E; Jadi R; Mallal S; De Silva AD; De Silva AM; Peters B; Weiskopf D; Sette A
    Front Immunol; 2019; 10():1568. PubMed ID: 31333679
    [No Abstract]   [Full Text] [Related]  

  • 80. A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants.
    Wang CY; Hwang KP; Kuo HK; Peng WJ; Shen YH; Kuo BS; Huang JH; Liu H; Ho YH; Lin F; Ding S; Liu Z; Wu HT; Huang CT; Lee YJ; Liu MC; Yang YC; Lu PL; Tsai HC; Lee CH; Shi ZY; Liu CE; Liao CH; Chang FY; Chen HC; Wang FD; Hou KL; Cheng J; Wang MS; Yang YT; Chiu HC; Jiang MH; Shih HY; Shen HY; Chang PY; Lan YR; Chen CT; Lin YL; Liang JJ; Liao CC; Chou YC; Morris MK; Hanson CV; Guirakhoo F; Hellerstein M; Yu HJ; King CC; Kemp T; Heppner DG; Monath TP
    J Clin Invest; 2022 May; 132(10):. PubMed ID: 35316221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.